Company intelligence / Profile preview

Arda Therapeutics

San Carlos, California, United Statesardatx.com ↗

Ownership: Private
Employees: ~15
Development stage: Preclinical

Overview

Arda Therapeutics has developed a proprietary platform that uses advanced single-cell analytics to identify pathogenic cells responsible for chronic diseases. Their approach enables the development of targeted biologic therapies that selectively eliminate these harmful cells while sparing healthy tissue. The company is advancing multiple preclinical programs with strong efficacy and safety data but has not yet entered clinical trials[2][3].

Therapeutic areas: OtherPulmonologyMetabolic DisordersImmunology
Modalities: Antibody-based biologicsMonoclonal antibodiesCell therapy[6]
Industry: Biotech

Beyond the preview

Go deeper on Arda Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arda Therapeutics.

Explore the full profile